1. Home
  2. STRO vs LSF Comparison

STRO vs LSF Comparison

Compare STRO & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • LSF
  • Stock Information
  • Founded
  • STRO 2003
  • LSF 2015
  • Country
  • STRO United States
  • LSF United States
  • Employees
  • STRO N/A
  • LSF N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • LSF Packaged Foods
  • Sector
  • STRO Health Care
  • LSF Consumer Staples
  • Exchange
  • STRO Nasdaq
  • LSF Nasdaq
  • Market Cap
  • STRO 77.7M
  • LSF 73.2M
  • IPO Year
  • STRO 2018
  • LSF 2020
  • Fundamental
  • Price
  • STRO $0.80
  • LSF $6.44
  • Analyst Decision
  • STRO Hold
  • LSF Strong Buy
  • Analyst Count
  • STRO 7
  • LSF 1
  • Target Price
  • STRO $3.97
  • LSF $12.00
  • AVG Volume (30 Days)
  • STRO 833.9K
  • LSF 30.3K
  • Earning Date
  • STRO 08-12-2025
  • LSF 08-06-2025
  • Dividend Yield
  • STRO N/A
  • LSF N/A
  • EPS Growth
  • STRO N/A
  • LSF N/A
  • EPS
  • STRO N/A
  • LSF N/A
  • Revenue
  • STRO $66,434,000.00
  • LSF $45,040,358.00
  • Revenue This Year
  • STRO N/A
  • LSF $23.40
  • Revenue Next Year
  • STRO N/A
  • LSF $20.11
  • P/E Ratio
  • STRO N/A
  • LSF N/A
  • Revenue Growth
  • STRO N/A
  • LSF 25.04
  • 52 Week Low
  • STRO $0.52
  • LSF $3.40
  • 52 Week High
  • STRO $5.17
  • LSF $10.90
  • Technical
  • Relative Strength Index (RSI)
  • STRO 46.11
  • LSF 48.59
  • Support Level
  • STRO $0.76
  • LSF $5.87
  • Resistance Level
  • STRO $0.94
  • LSF $6.77
  • Average True Range (ATR)
  • STRO 0.07
  • LSF 0.37
  • MACD
  • STRO -0.01
  • LSF -0.06
  • Stochastic Oscillator
  • STRO 29.11
  • LSF 51.82

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Share on Social Networks: